Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, is attracting significant attention from investors, particularly due to its bold foray into the treatment of obesity and..
Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical company based in the United Kingdom, is capturing the attention of investors with its transformative approach to cancer..
Abivax SA (ABVX), a prominent player in the biotechnology sector, is grabbing the spotlight with a potential upside of 355.74%, according to analysts’ target price projections...
Maze Therapeutics, Inc. (MAZE), a burgeoning entity within the biotechnology sector, is capturing attention with its compelling growth potential and strategic focus on precision medicines. With..
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biotech firm specializing in brain health medicines, has recently captured investor attention due to its intriguing potential upside. The company,..
Regulus Therapeutics Inc. (RGLS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to drug discovery. Specializing in targeting microRNAs..
Relay Therapeutics, Inc. (NASDAQ: RLAY) has been a subject of interest within the biotechnology sector, offering a compelling narrative for investors seeking opportunities in precision medicine...
Claritev Corporation (NASDAQ: CTEV) stands as a prominent player within the healthcare sector, specifically in the realm of health information services. With a market capitalization of..
Emergent BioSolutions Inc. (NYSE: EBS) presents a compelling opportunity for investors seeking high-risk, high-reward plays in the healthcare sector. With a market capitalization of $328.38 million,..
Sana Biotechnology, Inc. (NASDAQ: SANA), a promising player in the biotech landscape, is capturing the attention of investors with a staggering potential upside of 266.01%. The..
Talkspace, Inc. (NASDAQ: TALK) is drawing considerable attention from investors, thanks to its solid potential upside of 53.85% as indicated by recent analyst ratings. This New..
Celcuity Inc. (NASDAQ: CELC), a notable player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 141.94%. This clinical-stage biotech firm,..
REGENXBIO Inc. (RGNX), a pioneer in gene therapy, is capturing the attention of investors with its impressive 279.78% potential upside, backed by substantial revenue growth. As..
Investors with an interest in the biotechnology sector may want to pay close attention to Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a company with an ambitious portfolio..
Investors seeking opportunities in the healthcare sector might find Organogenesis Holdings Inc. (NASDAQ: ORGO) to be an intriguing contender, particularly given its substantial potential upside. Specializing..
ATAI Life Sciences N.V. (NASDAQ: ATAI), a clinical-stage biopharmaceutical company headquartered in Berlin, Germany, is making waves in the biotechnology sector with a remarkable potential upside..
Myriad Genetics, Inc. (NASDAQ: MYGN) presents an intriguing investment opportunity within the healthcare sector, specifically the diagnostics and research industry. With a market capitalization of approximately..
Fulgent Genetics, Inc. (NASDAQ: FLGT) presents a compelling case for investors interested in the healthcare sector, specifically within the diagnostics and research industry. With a market..
Kamada Ltd. (NASDAQ: KMDA), a prominent player in the healthcare sector, specifically within the drug manufacturing industry, is catching the eye of investors with an impressive..
Verastem, Inc. (NASDAQ: VSTM) is capturing investor attention with its ambitious pipeline in the oncology space and a striking potential upside of 154.85%, according to the..
